Related references
Note: Only part of the references are listed.CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
Gilles Darcis et al.
CELL REPORTS (2020)
A FcγRIIa polymorphism has aHLA-B57andHLA-B27independent effect on HIV disease outcome
Raphael Carapito et al.
GENES AND IMMUNITY (2020)
The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
Gilles Darcis et al.
VIRUSES-BASEL (2019)
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
John P. Thornhill et al.
MUCOSAL IMMUNOLOGY (2019)
Effect of Fc Receptor Genetic Diversity on HIV-1 Disease Pathogenesis
Daniel E. Geraghty et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial
Shuying S. Li et al.
JOURNAL OF VIROLOGY (2019)
FcγRIIIa receptor polymorphism influences NK cell mediated ADCC activity against HIV
Sneha Pramod Talathi et al.
BMC INFECTIOUS DISEASES (2019)
Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques
Matthew S. Parsons et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
Alessandra Noto et al.
JOURNAL OF VIROLOGY (2018)
CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells
Mohamed Abdel-Mohsen et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
Roger Badia et al.
NATURE COMMUNICATIONS (2018)
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
Martin R. Gaudinski et al.
PLOS MEDICINE (2018)
Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30
Louise E. Hogan et al.
PLOS PATHOGENS (2018)
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
Simone I. Richardson et al.
PLOS PATHOGENS (2018)
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
Genevieve E. Martin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells
Melissa Newling et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Conflicting evidence for HIV enrichment in CD32+ CD4 T cells
Liliana Perez et al.
NATURE (2018)
The role of CD32 during HIV-1 infection
Lynn N. Bertagnolli et al.
NATURE (2018)
Evidence that CD32a does not mark the HIV-1 latent reservoir
Christa E. Osuna et al.
NATURE (2018)
Fc-gamma receptor IIA and IIIA variants in two African cohorts: Lack of consistent impact on heterosexual HIV acquisition, viral control, and disease progression
Sarah Connolly et al.
VIROLOGY (2018)
Anti-retroviral antibody FcR-mediated effector functions
Stylianos Bournazos et al.
IMMUNOLOGICAL REVIEWS (2017)
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs
Hongru Li et al.
JOURNAL OF VIROLOGY (2017)
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Benjamin Descours et al.
NATURE (2017)
Systems serology: profiling vaccine induced humoral immunity against HIV
Amy W. Chung et al.
RETROVIROLOGY (2017)
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection
Matthew S. Parsons et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
HIV Latency: Should We Shock or Lock?
Gilles Darcis et al.
TRENDS IN IMMUNOLOGY (2017)
Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals
Luzia Mayr et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Non-Neutralizing Antibodies Directed against HIV and Their Functions
Luzia M. Mayr et al.
FRONTIERS IN IMMUNOLOGY (2017)
Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation
Brice J. Albert et al.
SCIENTIFIC REPORTS (2017)
Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG
Raymond A. Alvarez et al.
JCI INSIGHT (2017)
Variability at the FCGR locus: characterization in Black South Africans and evidence for ethnic variation in and out of Africa
R. Lassauniere et al.
GENES AND IMMUNITY (2016)
The influence of NK cell-mediated ADCC: Structure and expression of the CD16 molecule differ among FcγRIIIa-V158F genotypes in healthy Japanese subjects
Wataru Oboshi et al.
HUMAN IMMUNOLOGY (2016)
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks et al.
NATURE MEDICINE (2016)
Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility
Ria Lassauniere et al.
RETROVIROLOGY (2016)
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Ching-Lan Lu et al.
SCIENCE (2016)
HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART
Jintanat Ananworanich et al.
EBIOMEDICINE (2016)
Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection
Mark S. De Souza et al.
AIDS (2015)
Short Communication: Fc Gamma Receptors IIa and IIIa Genetic Polymorphisms Do Not Predict HIV-1 Disease Progression in Kenyan Women
Julie F. Weis et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection
Bin Su et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
The role of Fc receptors in HIV prevention and therapy
Austin W. Boesch et al.
IMMUNOLOGICAL REVIEWS (2015)
The impact of host genetic variation on infection with HIV-1
Paul J. McLaren et al.
NATURE IMMUNOLOGY (2015)
HIV-1 and interferons: who's interfering with whom?
Tomas Doyle et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
Wilton B. Williams et al.
SCIENCE (2015)
FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission
Caitlin Milligan et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes
Rui Kong et al.
JOURNAL OF VIROLOGY (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Emerging strategies to deplete the HIV reservoir
Nancie M. Archin et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy
Slim Fourati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S. Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells
Maria J. Buzon et al.
JOURNAL OF VIROLOGY (2014)
Broadly Neutralizing Antibody VRC01 Prevents HIV-1 Transmission from Plasmacytoid Dendritic Cells to CD4 T Lymphocytes
Bin Su et al.
JOURNAL OF VIROLOGY (2014)
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
Susan Zolla-Pazner et al.
PLOS ONE (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
HIV-1 Latency: An Update of Molecular Mechanisms and Therapeutic Strategies
Angela Battistini et al.
VIRUSES-BASEL (2014)
HIV-1 DNA predicts disease progression and post-treatment virological control.
James P. Williams et al.
ELIFE (2014)
High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy
Christopher J. A. Duncan et al.
AIDS (2013)
Prospects for Treatment of Latent HIV
K. M. Barton et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?
Christoph Neumann-Haefelin
CURRENT OPINION IN RHEUMATOLOGY (2013)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua-Xin Liao et al.
IMMUNITY (2013)
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Margaret E. Ackerman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
Marine Malbec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b
Margaret E. Ackerman et al.
JOURNAL OF VIROLOGY (2013)
Correlation of Fc-γ RIIA polymorphisms with latent Epstein-Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas
Panagiotis T. Diamantopoulos et al.
LEUKEMIA & LYMPHOMA (2013)
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H. Barouch et al.
NATURE (2013)
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
Susan Zolla-Pazner et al.
PLOS ONE (2013)
Copy Number Variation of Fc Gamma Receptor Genes in HIV-Infected and HIV-Tuberculosis Co-Infected Individuals in Sub-Saharan Africa
Lee R. Machado et al.
PLOS ONE (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A novel acute HIV infection staging system based on 4th generation immunoassay
Jintanat Ananworanich et al.
RETROVIROLOGY (2013)
Fc Gamma Receptor 3A Polymorphism and Risk for HIV-Associated Cryptococcal Disease
Soma Rohatgi et al.
MBIO (2013)
Frequency of FCGR3B Alleles in Thai Blood Donors
Chollanot Kaset et al.
ANNALS OF LABORATORY MEDICINE (2013)
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls
Paul J. McLaren et al.
PLOS PATHOGENS (2013)
Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination
Donald N. Forthal et al.
BLOOD (2012)
Genetic variants associated with severe pneumonia in A/H1N1 influenza infection
J. Zuniga et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replication
Raymond N. Deepe et al.
HUMAN IMMUNOLOGY (2012)
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Evelyn Eisele et al.
IMMUNITY (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fc Gamma Receptor IIIB (FcγRIIIB) Polymorphisms Are Associated with Clinical Malaria in Ghanaian Children
Bright Adu et al.
PLOS ONE (2012)
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Brian Moldt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
Irene A. Abela et al.
PLOS PATHOGENS (2012)
HLA/KIR Restraint of HIV: Surviving the Fittest
Arman A. Bashirova et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders
Gissel Garcia et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Activation of NK Cells by ADCC Antibodies and HIV Disease Progression
Amy W. Chung et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Epidemiology and clinical characteristics of elite controllers
Jason F. Okulicz et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
Laurent Hocqueloux et al.
AIDS (2010)
Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcγRIIa genotype
Martyn A. French et al.
AIDS (2010)
Asymptomatic Dengue Infection in a Cuban Population Confirms the Protective Role of the RR Variant of the FcγRIIa Polymorphism
Gissel Garcia et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Involvement of the Fc gamma receptor IIA cytoplasmic domain in anti body-dependent enhancement of dengue virus infection
Meng Ling Moi et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Virological Synapse-Mediated Spread of Human Immunodeficiency Virus Type 1 between T Cells Is Sensitive to Entry Inhibition
Nicola Martin et al.
JOURNAL OF VIROLOGY (2010)
Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression
Concepcion Casado et al.
PLOS ONE (2010)
High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression
Bhawna Poonia et al.
PLOS ONE (2010)
Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV
Sophie Grabar et al.
AIDS (2009)
The Fcγ Receptor IIA-R/R131 Genotype Is Associated with Severe Sepsis in Community-Acquired Pneumonia
Henrik Endeman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Fcγ receptors: structure, function and role as genetic risk factors in SLE
X. Li et al.
GENES AND IMMUNITY (2009)
HIV Infection Affects Blood Myeloid Dendritic Cells after Successful Therapy and despite Nonprogressing Clinical Disease
Julie Fontaine et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long-Term Nonprogressors in the US Department of Defense HIV Natural History Study
Jason F. Okulicz et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Fc receptor-mediated antiviral antibodies
Donald N. Forthal et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali
Elisabeth Israelsson et al.
MALARIA JOURNAL (2008)
Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura
Willernijn B. Breunis et al.
BLOOD (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
FcγRIIa genotype predicts progression of HIV infection
Donald N. Forthal et al.
JOURNAL OF IMMUNOLOGY (2007)
Influence of IFNγ co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy
S. Emery et al.
HUMAN VACCINES (2007)
Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses
Ping Chen et al.
JOURNAL OF VIROLOGY (2007)
Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism
Evdoxia Hatjiharissi et al.
BLOOD (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
The T cell costimulator TL1A is induced by FcγR signaling in human monocytes and dendritic cells
John L. Prehn et al.
JOURNAL OF IMMUNOLOGY (2007)
Fc gamma RIIB as a modulator of autoimmune disease susceptibility
Tatyana Tarasenko et al.
AUTOIMMUNITY (2007)
Regulated expression of FcyR in human dendritic cells controls cross-presentation of antigen-antibody complexes
Yi Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort
G. Diop et al.
BIOMEDICINE & PHARMACOTHERAPY (2006)
Randomized, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-γ in HIV-1 Infected Subjects
S. Emery et al.
HUMAN VACCINES (2005)
Influence of FcγRIIA and MBL polymorphisms on severe acute respiratory syndrome
FF Yuan et al.
TISSUE ANTIGENS (2005)
Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya
KC Brouwer et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies
L Ganesh et al.
JOURNAL OF VIROLOGY (2004)
Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal infants is HIV-1 infection
KC Brouwer et al.
AIDS (2004)
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
M Altfeld et al.
AIDS (2003)
FCGR3B gene frequencies and FCGR3 variants in a Chinese population from Zhejiang Province
Y Tong et al.
ANNALS OF HEMATOLOGY (2003)
Allelic polymorphisms in the FcγRIIC gene can influence its function on normal human natural killer cells
LK Ernst et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Evaluation of human FcγRIIA (CD32) and FcγRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA
RCAA van Schie et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2000)
C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific
MP Stein et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Association between Fc gamma RIIa-R131 allotype and bacteremic pneumococcal pneumonia
AMF Yee et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
